Introduction
============

Cervical intraepithelial neoplasia (CIN) is a precursor lesion of cervical cancer and is classified by histology as CIN 1, CIN 2, or CIN 3. Widespread cervical screening using cytology combined with human papilloma virus testing has resulted in a considerable increase in the number of women diagnosed with CIN in recent decades.[@b1-ott-9-3907] According to laboratory surveys from the College of American Pathologists,[@b2-ott-9-3907] more than 1 million women are found to have CIN 1 each year, and 500,000 are diagnosed with CIN 2 and CIN 3, which are referred to as high-grade CIN. As recommended by the American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines,[@b3-ott-9-3907] patients with CIN 1 are usually monitored by continued follow-up because the regression rates are high and progression to CIN 2+ is uncommon. Excisional treatment is mainly used to treat CIN 2/3, which might progress to invasive cervical cancer if left untreated. The management of CIN has been a public health burden in many parts of the world.

Currently, the two main excisional strategies for CIN treatment are loop electrosurgical excision procedure (LEEP) or large loop excision of the transformation zone (LLETZ) and cold-knife conization (CKC), which offers deep excision of the cervical transformation zone with minimal damage. CKC has been the traditional procedure for CIN and is typically performed in a hospital setting under general or local anesthesia. First described in 1989 by Prendiville,[@b4-ott-9-3907] LEEP has been the most commonly used method for CIN and has several advantages, including shorter operative time, ease of performance, and low cost.[@b5-ott-9-3907]

Recent years have seen an increase in studies reporting CIN treatments with success rates exceeding 90%.[@b6-ott-9-3907]--[@b9-ott-9-3907] However, these studies are inconsistent regarding the therapeutic efficacy and complications associated with the two procedures, and the 2012 ASCCP guidelines[@b3-ott-9-3907] do not make any recommendations indicating CKC or LEEP as the optimal therapy option. Although two reviews[@b10-ott-9-3907],[@b11-ott-9-3907] have been published previously, a more comprehensive meta-analysis focusing on treatment failures or operative morbidity and other previously unanalyzed factors is needed. The objective of this meta-analysis is to evaluate the superiority of LLETZ/LEEP versus CKC in the surgical treatment of CIN.

Materials and methods
=====================

Search strategy
---------------

Systematic searches were performed using the MEDLINE, EMBASE, Cochrane databases, and the China National Knowledge Infrastructure Databases (CNKI) to identify all articles published up to February 2016 involving patients with CIN treated with CKC or LEEP. The searches were restricted to English or Chinese language and included only human studies. The following terms were used to identify studies: "cervical intraepithelial neoplasia", or "cervical dysplasia", "large loop excision of the transformation zone" or "loop electrosurgical excisional procedure" or "cold knife conization". Because of the lack of details regarding research methods and results, abstracts and unpublished works were not included. Searches of the title and abstract of each article were independently conducted by YMJ and LL to determine potentially relevant studies.

Study selection and data extraction
-----------------------------------

Studies comparing the efficacy of LEEP and CKC to patients with CIN were included. Studies in which more than one treatment procedure was used but the outcomes for each treatment procedure were not reported separately were excluded. We also excluded case reports and studies undertaken during pregnancy. The primary outcome included the rates of residual disease, recurrent disease, positive margins, secondary hemorrhage, cervical stenosis at follow-up, cone depth, and pregnancy outcomes. To determine the validity of the studies, a modified Jadad scale was used to assess the quality of the included randomized studies.[@b12-ott-9-3907] For nonrandomized studies, the Newcastle--Ottawa score was determined.[@b13-ott-9-3907] The data were independently extracted from each included study by YMJ and LL, and any disagreements were resolved by consensus with a third review author (CXC) as necessary.

Data synthesis
--------------

We extracted data from the experimental and the control group for every observed outcome. Relative risks (RRs) or weighted mean difference (MD) with 95% confidence intervals (CIs) were calculated with Revman 5.3 software (Cochrane Informatics & Knowledge Management Department, Copenhagen, Denmark), and heterogeneity was quantified using the *I*^2^ statistic.[@b14-ott-9-3907] If heterogeneity is accepted at *I*^2^\<50%, a fixed-effects model was used for the meta-analysis. Otherwise, a random effects model was used. Statistical significance was defined as a *P*-value less than 0.05. Sensitivity analyses based on randomized or nonrandomized trials were performed.

Results
=======

Study identification and selection
----------------------------------

We reviewed 112 potentially relevant eligible studies. Based on the inclusion criteria, seven randomized controlled studies, one prospective cohort study, and twelve retrospective cohort studies were included ([Figure 1](#f1-ott-9-3907){ref-type="fig"}). The vast majority of the participants had CIN 2--3, although some patients with CIN 1 were included because the ASCCP consensus guidelines were not updated until 2006 with the suggestion that CIN 1 could be managed conservatively in adults.[@b15-ott-9-3907] The follow-up period ranged from 3 months to 23 years. The mean age ranged from 27.3 to 43.8 years. [Table 1](#t1-ott-9-3907){ref-type="table"} lists the main characteristics of the 20 included studies involving 5,709 patients.[@b5-ott-9-3907]--[@b9-ott-9-3907],[@b16-ott-9-3907]--[@b30-ott-9-3907] [Table 1](#t1-ott-9-3907){ref-type="table"} shows the Newcastle--Ottawa scores and the modified Jadad scale for the quality assessment of the nonrandomized studies and randomized studies. The quality was not high for any of the studies.

Recurrence rate
---------------

Seven studies, including two randomized controlled trials (RCTs)[@b6-ott-9-3907],[@b7-ott-9-3907] and five non-RCTs,[@b17-ott-9-3907]--[@b21-ott-9-3907] reported recurrence rates, and the results of the individual studies varied. A meta-analysis based on all these seven studies revealed that patients in CKC group had slightly lower recurrence rate than those in LLETZ/LEEP group (RR =1.75, 95% CI =0.99--3.11, *P*=0.06; [Figure 2](#f2-ott-9-3907){ref-type="fig"}). Moreover, subgroup analyses based on RCTs or non-RCTs also showed similar results ([Figure 2](#f2-ott-9-3907){ref-type="fig"}).

Positive margin rate
--------------------

One RCT[@b7-ott-9-3907] and eight non-RCTs[@b9-ott-9-3907],[@b19-ott-9-3907],[@b22-ott-9-3907]--[@b26-ott-9-3907] described positive margin rate. The prevalence of positive margins was 22% (343/1,595) after LLETZ/LEEP and 13% (200/1,596) after CKC. Pooled results exhibited no statistical significance based on all nine studies (RR =1.45; 95% CI =0.85--2.49, *P*=0.17) ([Figure 3](#f3-ott-9-3907){ref-type="fig"}).

Residual disease rate
---------------------

Three RCTs[@b5-ott-9-3907]--[@b7-ott-9-3907] and one non-RCT[@b27-ott-9-3907] described the rate of residual disease. Results from individual studies showed no differences between LLETZ/LEEP and CKC group. Pooled results of all four studies (RR =1.15, 95% CI =0.73--1.81, *P*=0.48) or all three RCTs confirmed that there was no evidence of significant differences in residual disease rate ([Figure 4](#f4-ott-9-3907){ref-type="fig"}).

Pregnancy outcomes
------------------

The differences in pregnancy outcomes between LLETZ/LEEP and CKC were evaluated in two RCTs[@b6-ott-9-3907],[@b28-ott-9-3907] and one non-RCT[@b29-ott-9-3907] with small sample size. Michelin et al[@b29-ott-9-3907] reported that miscarriages and preterm pregnancies were more frequent in CKC cases versus LEEP: 26% and 5.2%, and 23% and 5.5%, respectively. Liu et al[@b28-ott-9-3907] concluded that the rates of preterm premature rupture of membranes (*P*=0.03), preterm delivery (*P*=0.04) and low-birth-weight infants (\<2,500 g) (*P*=0.04) were higher in the CKC group than in the LEEP group, but there were no differences in the mean birth weight, cesarean delivery, labor induction, or neonatal intensive care unit admission. Mathevet et al[@b6-ott-9-3907] reported that there was no major difference in obstetrical outcomes between CKC and LLETZ/LEEP techniques.

Secondary hemorrhage
--------------------

The results regarding secondary hemorrhage were reported by five RCTs[@b5-ott-9-3907]--[@b8-ott-9-3907],[@b30-ott-9-3907] and three non-RCTs.[@b9-ott-9-3907],[@b18-ott-9-3907],[@b27-ott-9-3907] The results of the included individual studies did not differ significantly. After the pooled meta-analysis of the eight studies, the RR for secondary hemorrhage was not different between LLETZ/LEEP and CKC groups based on all eight studies (RR =1.16, 95% CI =0.74--1.81; *P*=0.46) ([Figure 5](#f5-ott-9-3907){ref-type="fig"}).

Cervical stenosis
-----------------

Cervical stenosis results were based on three RCTs[@b6-ott-9-3907],[@b7-ott-9-3907],[@b16-ott-9-3907] and two non-RCTs.[@b9-ott-9-3907],[@b19-ott-9-3907] As shown in [Figure 6](#f6-ott-9-3907){ref-type="fig"}, the pooled meta-analyses showed that the results were not significantly different across all studies or the RCT subgroup (all *P*\>0.05). However, the opposite result was found in the non-RCT subgroup (RR =0.13, 95% CI =0.02--0.67; *P*=0.02).

Cone depth
----------

As shown in [Figure 7](#f7-ott-9-3907){ref-type="fig"}, the cone depth was reported in two RCTs.[@b5-ott-9-3907],[@b6-ott-9-3907] The two individual studies showed that women treated with CKC had a significantly deeper cervical cone than those treated with LLETZ/LEEP. The pooled results also indicated that cone depth of CKC was statistically deeper (MD =−5.71, 95% CI =−7.45 to −3.96; *P*\<0.001).

Discussion
==========

In this review, we found 20 studies in which LLETZ/LEEP was compared with CKC for the treatment of CIN. Differences between the included studies in terms of their setting, research protocol, patient characteristics, and efficacy were observed. No significant heterogeneity was detected across studies for any of the data evaluated, except for the rates of positive surgical margins and recurrences.

A previous review[@b31-ott-9-3907] reported that the prevalence of residual and recurrent disease after incomplete LEEP did not differ significantly (22%; 766/3,476) compared with the results after knife-cone biopsy (27%; 445/1,661). That review did not differentiate between residual and recurrent disease. The availability of the new studies increased the statistical power and sample size and, to the best of our knowledge, enabled us to compare for the first time the differences in recurrence rates and positive margin rates. With respect to efficacy, we concluded that the recurrence rate is not significantly different between the two methods.

Incomplete excision of CIN exposes women to a high risk of high-grade cervical disease posttreatment.[@b31-ott-9-3907] High-grade posttreatment disease occurred in 18% (597/3,335) of women who had incomplete excision compared with 3% (318/12,493) who had complete excision.[@b31-ott-9-3907] This poses a challenge for doctors in choosing appropriate options so as to avoid residual disease resulting from incomplete excision during conization. Disease recurrence is the main problem during the 5-year follow-up period because the risk of recurrence remains elevated for 8 years or more after treatment for CIN.[@b32-ott-9-3907] Serati et al[@b20-ott-9-3907] found that 22.7% of women developed histologically confirmed recurrence, which does not appear to depend on the surgical technique used. Another study showed that recurrences occurred after 5--31 months in 7.1% and 11.2% of the patients who underwent LEEP and CKC, respectively, and had negative histological findings on surgical specimens.[@b21-ott-9-3907] In this meta-analysis, no significant differences in the rates of recurrence or residual disease between the LLETZ/LEEP and CKC groups were observed. The results appear to suggest that LLETZ/LEEP is as effective as CKC in the surgical treatment of CIN and that there is no significant difference in recurrence or residual disease. However, larger sample size and longer follow-up randomized studies are necessary to further confirm these findings.

Increasing concerns have been raised regarding the rate of positive margins after the treatment of CIN, and the effects of different surgical treatments on the positive margin rate remain unclear. In previous years, there was no significant difference in the rates of positive margins reported between the two groups, but in recent years, as the case numbers increased, the results have varied. In our analysis, the rate of positive margins after LLETZ/LEEP was 22% (343/1,595); the rate of positive margins after CKC was 13% (200/1,596). These rates were both lower than previous reports; a possible explanation for these lower rates is that more importance was assigned to the problem of positive margins later. Our pooled analysis indicated that LLETZ/LEEP was associated with a higher incidence of positive margins, which might be because of the significantly deeper conization of CKC and the removal of occult endocervical lesions. The age of the woman is another important factor in determining surgical options. In one study included in this meta-analysis, Shin et al[@b24-ott-9-3907] found that in patients aged \>45 years, the LLETZ/LEEP group had significantly higher rate of nonnegative surgical margins compared with the CKC group. This result suggests that the use of LLETZ/LEEP might not be recommended if achieving complete negative margin is the only consideration, especially for older women. However, heterogeneity and bias were noted in these data and could be ascribed to the effects of small studies. It was recently reported that for adenocarcinoma in situ of the cervix, positive margins were found in 18% of the women treated with CKC versus 40% of the women treated with LLETZ/LEEP.[@b33-ott-9-3907] Based on these results, further research should be performed to evaluate whether LLETZ/LEEP can increase the positive margin rate for cervical precancerous lesions.

In theory, a higher positive margin rate after treatment of CIN should lead to greater recurrence during the follow-up period. A positive surgical margin was a high risk factor for residual disease or relapse after conization of CIN.[@b34-ott-9-3907] However, an inconsistent relationship appears to exist between positive surgical margins and recurrence in the two groups in our meta-analysis. Evidence-based research has reported a similar discrepancy; the rate of disease recurrence/persistence in women with positive margins who were followed up was only 9.3%.[@b22-ott-9-3907] A possible explanation for this result is that not all of the women with positive surgical margins had residual disease, and longer follow-up periods would be beneficial.

Kyrgiou et al[@b35-ott-9-3907] focused on pregnancy outcomes in a previous meta-analysis and found that CKC and LLETZ/LEEP were significantly associated with preterm delivery and low birth weight and that CKC was associated with higher relative risks than LLETZ/LEEP. However, this meta-analysis compared groups with or without a previous conservative intervention on the cervix and did not compare CKC and LLETZ/LEEP groups. We did not identify any meta-analyses comparing pregnancy outcomes between these two procedures. The pooled analysis in our study was not evaluated because of the small sample size. The main findings regarding pregnancy outcomes are consistent with the results of the previous meta-analysis. The available evidence suggested that differences in pregnancy outcomes, such as the rate of miscarriage and low birth weight, between CKC and LLETZ/LEEP were observed in our study. Women with a history of CKC treatment were found to have an increased risk of preterm delivery compared to those with a history of LLETZ/LEEP treatment.[@b28-ott-9-3907],[@b29-ott-9-3907] Few studies on the effects of LLETZ/LEEP and CKC have adequate power to detect a significant difference on subsequent pregnancy. LLETZ/LEEP is more appropriate for patients with CIN for future pregnancies compared with CKC. Moreover, we must take note of the new recommendation by tailoring excision treatment according to the type of the transformation zone to try to avoid unnecessary excision of healthy cervical tissue.[@b36-ott-9-3907]

Limitations
===========

Several limitations of this meta-analysis should be considered. First, some of the included studies were retrospective in nature; therefore, there might have been confounders that were not recognized or controlled. However, a subgroup analysis of the data extracted from the studies revealed similar results. Second, the follow-up time, patient age, and disease degree varied among the included studies, and these differences may have affected the results. Finally, it is possible that the exclusion of some missing and unpublished data might have led to a bias in the effect.

Conclusion
==========

The present meta-analysis showed that there was no significant difference regarding residual and recurrence rate in LLETZ/LEEP compared with CKC for treating CIN. A woman should select the surgical procedure after discussing the benefits and risks with her surgeon. Further large-scale and high-quality RCTs are needed to confirm the best procedure.
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![Study selection and exclusion process.\
**Abbreviations:** LEEP, loop electrosurgical excision procedure; CKC, cold-knife conization.](ott-9-3907Fig1){#f1-ott-9-3907}

![Comparison of LLETZ/LEEP and CKC in recurrence rate.\
**Abbreviations:** LLETZ, large loop excision of the transformation zone; LEEP, loop electrosurgical excision procedure; CKC, cold-knife conization; CI, confidence interval; *df*, degrees of freedom; M--H, Mantel--Haenszel test.](ott-9-3907Fig2){#f2-ott-9-3907}

![Comparison of LLETZ/LEEP and CKC in positive margin.\
**Abbreviations:** LLETZ, large loop excision of the transformation zone; LEEP, loop electrosurgical excision procedure; CKC, cold-knife conization; CI, confidence interval; *df*, degrees of freedom; M--H, Mantel--Haenszel test.](ott-9-3907Fig3){#f3-ott-9-3907}

![Comparison of LLETZ/LEEP and CKC in residual disease.\
**Abbreviations:** LLETZ, large loop excision of the transformation zone; LEEP, loop electrosurgical excision procedure; CKC, cold-knife conization; CI, confidence interval; *df*, degrees of freedom; M--H, Mantel--Haenszel test.](ott-9-3907Fig4){#f4-ott-9-3907}

![Comparison of LLETZ/LEEP and CKC in secondary hemorrhage.\
**Abbreviations:** LLETZ, large loop excision of the transformation zone; LEEP, loop electrosurgical excision procedure; CKC, cold-knife conization; CI, confidence interval; *df*, degrees of freedom; M--H, Mantel--Haenszel test.](ott-9-3907Fig5){#f5-ott-9-3907}

![Comparison of LLETZ/LEEP and CKC in cervical stenosis.\
**Abbreviations:** LLETZ, large loop excision of the transformation zone; LEEP, loop electrosurgical excision procedure; CKC, cold-knife conization; CI, confidence interval; *df*, degrees of freedom; M--H, Mantel--Haenszel test.](ott-9-3907Fig6){#f6-ott-9-3907}

![Comparison of LLETZ/LEEP and CKC in cone depth.\
**Abbreviations:** LLETZ, large loop excision of the transformation zone; LEEP, loop electrosurgical excision procedure; CKC, cold-knife conization; SD, standard deviation; CI, confidence interval; *df*, degrees of freedom; IV, independent variable.](ott-9-3907Fig7){#f7-ott-9-3907}

###### 

Characteristics of the included studies

  Source                                      Intervention   Histology   Study design   Study period                      Follow-up period   Outcomes              Quality score[a](#tfn1-ott-9-3907){ref-type="table-fn"}                                  
  ------------------------------------------- -------------- ----------- -------------- --------------------------------- ------------------ --------------------- ---------------------------------------------------------------------------------------- ---
  Giacalone et al[@b5-ott-9-3907]             38             28          CIN 2--3       RCT                               1997--1998         3 months              Residual disease, secondary hemorrhage                                                   4
  Mathevet et al[@b6-ott-9-3907]              36             37          CIN 1--3       RCT                               1990--1992         6 months              Residual disease, secondary hemorrhage, cervical stenosis                                5
  Duggan et al[@b7-ott-9-3907]                89             85          CIN 1--3       RCT                               1992--1994         12 months             Recurrence, positive margin, residual disease, secondary hemorrhage, cervical stenosis   5
  Takač and Gorišek[@b8-ott-9-3907]           120            120         CIN 1--3       RCT                               1993--1996         3 months              Secondary hemorrhage                                                                     3
  Bozanovic et al[@b9-ott-9-3907]             72             100         CIN 1--3       Retrospective study               NA                 Over 2 years          Positive margin, secondary hemorrhage, cervical stenosis                                 7
  Mathevet et al[@b16-ott-9-3907]             29             28          CIN 2--3       RCT                               NA                 38--118 months        Recurrence, cervical stenosis, cesarean section, miscarriage rate, preterm delivery      5
  Gonzalez-Bosquet et al[@b17-ott-9-3907]     58             25          CIN 1--3       Prospective multicenter project   1991--1994         NA                    Recurrence                                                                               9
  Zeng et al[@b18-ott-9-3907]                 74             869         NA             Retrospective study               2002--2007         12--78 months         Recurrence, secondary hemorrhage                                                         7
  Bornstein et al[@b19-ott-9-3907]            52             22          CIN 2--3       Retrospective study               1983--1993         NA                    Cone size, recurrence, positive margin, cervical stenosis                                8
  Serati et al[@b20-ott-9-3907]               214            68          CIN 1--3       Retrospective cohort study        1999--2009         6--100 months         Recurrence                                                                               6
  Murta et al[@b21-ott-9-3907]                101            142         CIN 1--3       Retrospective study               1981--2003         ≥16 months            Recurrence                                                                               8
  Chen et al[@b22-ott-9-3907]                 453            660         NA             Retrospective cohort study        2006--2009         8 months to 8 years   Positive margin                                                                          8
  Grimm et al[@b23-ott-9-3907]                412            392         CIN 1--3       Retrospective multicenter study   2004--2009         NA                    Positive margin                                                                          7
  Shin et al[@b24-ott-9-3907]                 79             39          CIN 1--3       Retrospective study               2005--2006         NA                    Positive margin                                                                          7
  Miroshnichenko et al[@b25-ott-9-3907]       96             61          NA             Retrospective study               2003--2007         NA                    Positive margin                                                                          7
  Panna and Luanratanakorn[@b26-ott-9-3907]   269            194         NA             Retrospective study               2002--2007         NA                    Positive margin                                                                          9
  Huang and Hwang[@b27-ott-9-3907]            73             43          NA             Retrospective study               1992--1997         NA                    Positive margin, residual disease, secondary hemorrhage                                  9
  Liu et al[@b28-ott-9-3907]                  124            120         CIN 3          RCT                               2006--2009         NA                    Cesarean delivery, preterm delivery, low birth weight, miscarriage rate                  3
  Michelin et al[@b29-ott-9-3907]             95             102         CIN 1--3       Retrospective study               1981--2004         1--23 years           Preterm delivery, low birth weight, miscarriage rate                                     9
  Girardi et al[@b30-ott-9-3907]              38             52          CIN 1--3       RCT                               NA                 10 months             Cone depth, secondary hemorrhage                                                         3

**Notes:**

Quality assessment: the modified Jadad scale was used for RCTs, and the Newcastle--Ottawa score was used for nonrandomized studies.

**Abbreviations:** LEEP, loop electrosurgical excision procedure; CKC, cold-knife conization; CIN, Cervical intraepithelial neoplasia; RCT, randomized controlled trial; NA, not available.
